Impact of diabetes (type 2) and glycemic control on health-related outcomes of patients receiving chemotherapy for non-metastatic breast cancer: a retrospective analysis.

Allison L Phillips David J Reeves Susan Storey

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2023)

Diabetes and glycemic control may impact the health-related outcomes of NMBC patients. Additional studies are needed to confirm these findings and determine optimal monitoring and management strategies for NMBC patients with diabetes and/or poor glycemic control during cytotoxic chemotherapy.

Keyphrases

glycemic control
type diabetes
blood glucose
metastatic breast cancer
weight loss
end stage renal disease
insulin resistance
newly diagnosed
chronic kidney disease
locally advanced
ejection fraction
peritoneal dialysis
squamous cell carcinoma
metabolic syndrome
radiation therapy
rectal cancer